Open Access

Screening of filamentous fungi for antimicrobial silver nanoparticles synthesis

  • Cristiane Angélica Ottoni1, 4Email author,
  • Marta Filipa Simões2,
  • Sara Fernandes3,
  • Jonas Gomes dos Santos4,
  • Elda Sabino da Silva4,
  • Rodrigo Fernando Brambilla de Souza5 and
  • Alfredo Eduardo Maiorano4
AMB Express20177:31

https://doi.org/10.1186/s13568-017-0332-2

Received: 23 November 2016

Accepted: 23 January 2017

Published: 1 February 2017

Abstract

The present work had the goal of screening a batch of 20 fungal strains, isolated from sugar cane plantation soil, in order to identify those capable of biosynthesis of silver nanoparticles. These nanoparticles are known to have a large and effective application in clinical microbiology. Four strains were found to be capable of biosynthesis of silver nanoparticles. The biosynthesised nanoparticles were characterised by UV–vis spectroscopy, scanning electron microscopy, EDX, and XRD. They were found to have an average size of 30–100 nm, a regular round shape, and potential antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. The antimicrobial activity was found to be directly related to the nanoparticles concentration. Mycogenic synthesis of nanoparticles is a green biogenic process preferable to other alternatives. Because fungi are great producers of extracellular enzymes this process makes scaling-up an easier task with high importance for clinical microbiology on the fight against microbial resistance, as well as for other industrial applications.

Keywords

Silver nanoparticles Filamentous fungi Mycogenic synthesis Nitrate-reductase Antimicrobial

Introduction

The rise of bacterial and fungal resistance against antimicrobials has promoted research of bactericidal nanomaterials, especially in the well-known area of silver ions and silver-based compounds, including silver nanoparticles (Jiravova et al. 2016; Monteiro et al. 2009). The latter have emerged as interesting antimicrobial agents due to their high surface-area-to-volume ratio and unique chemical and physical properties. They were previously described as “the largest and fastest growing category of nanotechnology-based medicines” (Chen et al. 2016), and provide a wide range of possible applications in areas as diverse as biomedical (prosthetics bone, surgical instruments), fashion (clothes and footwear production), beauty industry (conditioners, toothpaste), and clinical (for the treatment of wounds and infections) (Paschoalino et al. 2010; Durán et al. 2016). Their high demand makes it essential to develop environmentally benign procedures to synthesize silver nanoparticles for industrial and clinical purposes. A promising, reliable and eco-friendly approach is the use of natural sources and biological systems (Thakkar et al. 2010). A vast array of biological resources is available for this synthesis process, including: plants and plant products (Mittal et al. 2013), algae (Patel et al. 2015), fungi (Xue et al. 2016), yeast (Ortega et al. 2015) and bacteria (Pantidos and Horsfall 2014).

Among all biological resources, fungi present higher tolerance and metal bioaccumulation abilities, which are advantageous characteristics for the production of nanoparticles (Mandal et al. 2006). Another benefit of using fungi in nanoparticle synthesis is the ease in the scale-up which makes the entire process more cost-effective (Rahimi et al. 2016). Given that fungi are extremely efficient secretors of extracellular enzymes, it is thus possible to easily obtain large-scale production of nanoparticles (van den Hondel et al. 1992; Rahimi et al. 2016).

Also, exploring less studied environments can present new and different data on microbial diversity. Sugar cane plantation soil has not been thoroughly explored, but it has been reported that Aspergillus and Rhizopus are the dominant fungal genera present (Abdel-Rahim et al. 1983), and both have been described as being capable of AgNP synthesis (Banu et al. 2011; Zomorodian et al. 2016).

The underlying mechanisms of nanoparticles biosynthesis is yet to be fully elucidated. Although several factors acting together may determine the biological synthesis reaction, the identification of the most active biomolecules as reducing and stabilizing agents is essential in choosing the best technical parameters to be employed in the biosynthesis (Duschak 2016).

Biologically synthesized silver nanoparticles, are nontoxic for humans (in low concentrations), and safe inorganic antibacterial agents that have been shown to exhibit a strong toxicity to a wide range of microorganisms since ancient times (Shanthi et al. 2016; Roy et al. 2013; Annamalai and Nallamuthu 2016). It has been considered that AgNP mode of action depends on monovalent ionic silver (Ag+), which is released inside the microbial cells and inhibits microbial growth through suppression of respiratory enzymes and electron transport components (Li et al. 2006; Annamalai and Nallamuthu 2016; Chen et al. 2016). It has also been described that the AgNP affect the cellular membranes (Chen et al. 2016; Durán et al. 2016).

The present study aimed to: (1) identify different filamentous fungal strains capable of synthesizing silver nanoparticles (AgNP), (2) characterise the synthesised AgNP, and (3) analyse the antimicrobial activity of the produced nanoparticles against Gram-negative and -positive bacteria.

Materials and methods

Chemical compounds

Silver nitrate (PubChem CID: 24,470); sulphanilamide (PubChem CID: 5333); N-(1-naphthyl) ethylene diamine dihydrochloride (PubChem CID: 15,106); potassium nitrate (PubChem CID: 24,434); propanol (PubChem CID: 3776).

Microorganisms

A batch of 20 different filamentous fungal strains (identified as: IPT825, IPT827, IPT829, IPT849, IPT853, IPT859, IPT868, IPT856, IPT1005, IPT1008, IPT1009, IPT1010, IPT1011, IPT1012, IPT1013, IPT1014, IPT1015, IPT1016, IPT1017, and IPT1018), previously isolated from sugar cane plantation soil, was supplied by Instituto de Pesquisa Tecnológica do Estado de São Paulo (IPT, São Paulo, Brazil). All strains were maintained on malt extract agar (MEA; 20 g/L malt extract, 20 g/L glucose, 1 g/L peptone and 15 g/L agar) as stock cultures at 4 °C. These were maintained by regular subculturing.

Biosynthesis of silver nanoparticles

All 20 strains were screened for the biosynthesis of AgNP through the process hereby described. From the stock cultures grown in MEA, a 6 mm diameter disk from the peripheral area of the colony was transferred into a new Petri dish containing malt-glucose-yeast and peptone (MGYP) medium (3.0 g/L malt extract, 10.0 g/L glucose, 3.0 g/L yeast extract, 5.0 g/L peptone and 15 g/L agar) and incubated for 7 days at 30 °C in the dark. Fungal biomass was obtained by inoculating 5 culture disks (6 mm diameter) of each strain in Erlenmeyer flasks containing 100 mL of MGYP broth (3.0 g/L malt extract, 10.0 g/L glucose, 3.0 g/L yeast extract, and 5.0 g/L peptone). Cultures were incubated in an orbital shaker (Quimis, Brazil), for 120 h at 30 °C and 200 rpm. Biomass was then harvested by filtration through Whatman filter paper Grade 3 and was washed three times with sterile distilled water. Wet fungal mycelia (10 g) were suspended in 100 mL of sterilised distilled water and incubated at 30 °C with agitation (200 rpm) for 72 h. After this period, cell-free filtrate was collected by filtration through Whatman filter paper Grade 3. Suspensions were filtrated through a 0.22 µm filter (Millipore) and treated with a silver nitrate (AgNO3) solution (1 mM), followed by incubation at 30 °C with agitation (200 rpm), for 120 h in the dark.

UV–vis absorption spectra (UV–vis)

UV–vis is a widespread method of detection of AgNP (Chan and Don 2012). When bioreduction of AgNP occurred, a change in colour was observed in the AgNO3 solution, which turned from yellow into brown. This effect has been reported as an indicator of surface plasmon resonance (SPR) of AgNP (Chan and Don 2013). The position of the plasmonic band detected on the solutions of metallic nanoparticles is dependent on several parameters such as: size, shape, and polydispersity of particles. And, the more the narrow is the band, the bigger is the uniformity index of distribution according to AgNPs size (Becaro et al. 2015). Even though, there was no monitoring of the increase in absorbance until its maximum value, it has been described in the literature that the incubation period used in this study allows for the detection of maximum absorbance, implying the maximum concentration of synthesised AgNPs (Muthukrishnan et al. 2015). The UV–visible spectra of this solution was then recorded on UV–Vis Hitachi U-2000 spectrophotometer (Hitachi, Japan) in a range between 200 and 800 nm.

Transmission electron microscopy (TEM) and energy-dispersive X-ray analysis (EDX)

The size and shape of the synthesized AgNP were also determined by transmission electron microscopy (TEM) as described by Singhal et al. (2011). A JEOL electronic microscope (model JEM-2100) operated at 200 kV was used for TEM analysis. The average nanoparticle sizes were measured by counting approximately 100 nanoparticles in different regions of each sample, which were then used for the construction of histograms and determination of the average size of the nanoparticles. Energy dispersive X-ray spectroscopy (EDX), model JEOL-JSM 5410 LV (JEOL, USA). To prepare each sample, AgNP were sonicated for 5 min, and a drop of a diluted sample was placed onto a carbon-coated copper grid for analysis.

X-ray diffraction analysis (XRD)

X-ray diffraction was carried out using a Rigaku, Miniflex II diffractometer (Rigaku, Brazil), equipped with Cu Kα (0.15406 nm) at 40 kV and 30 mA. The diffractograms were recorded over the range 20–90 angles. Lyophilized nanoparticles were placed on a glass grid containing silicon substrate for XRD analysis.

Size and distribution analysis

For the aqueous suspension containing the AgNP, previously filtered through a 0.22 μm filter, the size distribution and average size of the synthesized AgNP were determined by Dynamic Light Scattering (DLS), Zetasizer Nano ZS90 (Malvern Instruments, UK).

Nitrate reductase activity

Nitrate reductase activity in the fungal filtrate was assayed by determining the presence of the extracellular enzyme according to the procedure described by Hamedi et al. (2013). Succinctly, the cell filtrate (5 mL) was mixed with an assay medium (30 mM KNO3 and 5% propanol in 0.1 M phosphate buffer pH 7.5) in a 1:1 (v/v) proportion and incubated at 30 °C, in the absence of light for 1 h. A sulphanilamide (SA) solution and a N-(1-naphthyl) ethylene diamine dihydrochloride (NEED) solution were added to the mixture. The released nitrites on the assay medium then reacted with the SA and NEED solutions and converted into a pink azodye. The absorbance of the resultant pink solutions was measured by UV–visible spectrophotometry, at 540 nm. The enzyme activity of the fungal cell-free filtrate was determined based on the increase in nitrite content of the solution over 1 h and expressed as nmol nitrite/h mL.

Antibacterial assay of silver nanoparticles

The antimicrobial activities against the Gram-positive bacteria: Staphylococcus aureus IPT246; and the Gram-negative bacteria: Escherichia coli IPT245, and Pseudomonas aeruginosa IPT322, were determined by agar plate well diffusion assay. Bacteria were cultured in Mueller–Hinton agar (MHA; 2.0 g/L beef extract, 17.5 g/L casein hydrolysate, 1.5 g/L starch, and 17 g/L agar), MHA, applying 100 μL of an initial inocullum (106 CFU/mL) of each strain in the agarised media and uniformly spreading. Subsequently, 100 μL of a AgNP solution at 1.0, 5.0, 10, 50, and 100 μg/mL concentrations were added into 3 mm diameter wells, cut out in the centre of the plate, and incubated at 37 °C for 24 h. Streptomycin solutions (100 μL) were used, in the same concentration values, as positive control, and water as negative control. After incubation, the zones of inhibition were measured. The assays were performed in triplicate.

Results

Silver nanoparticles biosynthesis

The synthesis of AgNP was detected by UV–vis, and from all the strains screened, only four had the aptitude to synthesize AgNP. Those were identified at IPT as: Rhizopus arrhizus IPT1011, Rhizopus arrhizus IPT1013, Trichoderma gamsii IPT853, and Aspergillus niger IPT856. The development of a brown colour was indicative of the formation of AgNP by ion reduction. AgNP were detected by the absorbance peak at 418–430 nm after 72 h of incubation.

UV–vis absorption spectra (UV–vis)

The intense dark brown colour of the fungal filtrate occurred after the addition of AgNO3, after a 24 h time period as seen on the representative image (Fig. 1). After 72 h, the maximum absorption values of the analysed strains were: 418 nm (IPT1011), 420 nm (IPT1013), 426 nm (IPT853) and 430 nm (IPT856). For all the filtrates with no addition of AgNO3, a peak between 279 and 285 nm was detected, which has been previously described as being common for biomolecules (Gopinath and Velusamy 2013).
Fig. 1

Colour change, for the strain IPT 1013, between a initial and b finishing step of the mycogenic reaction

Transmission electron microscopy (TEM) and energy-dispersive X-ray analysis (EDX)

All the biosynthesised AgNP presented a spherical shape and their respective histograms are shown in Fig. 2. The data observed in the histograms, is presented in Table 1.
Fig. 2

TEM images and respective histograms of AgNP synthesized by: a IPT853, b IPT856, c IPT1011, and d IPT1013

Table 1

Size and charge characteristics of synthesized AgNP

Nanoparticles

SEM average size (nm) (images not shown)

TEM

DLS average size

Zeta potential (in water) (mV)

Average size (nm)

AgNP with the average size (%)

IPT853

55.1

50

70

63.8

−16.53

IPT856

66.7

70

80

79.3

−28.40

IPT1011

31.6

50

70

53.0

−19.24

IPT1013

36.4

70

80

82.6

−21.35

EDX characterisation has shown absorption of strong silver signal (Fig. 3). The absorption peak at 3 keV is typical of crystalline nature of the AgNP.
Fig. 3

EDX spectra of AgNP synthesized by: a IPT853, b IPT856, c IPT1011, and d IPT1013

X-ray diffraction analysis (XDR)

Regarding XRD analysis (Fig. 4), it was possible to observe a well-defined face-centered cubic (FCC) structure of Ag for all materials, at 38°, 44°, 64.5°, 77°, and 82°, corresponding to planes (1 1 1), (2 0 0), (2 2 0), (3 1 1), (2 2 2) respectively and lattice parameter at 0.409 nm according to JCPDF # 04-783.
Fig. 4

XRD patterns of synthesized AgNP. Black line is Ag, grey line is AgO, grey dash is Ag2O2 and black dotted line is C

Using the Debye–Scherrer method (Cullity, 1967), the measured average crystallite size of AgNP for each strain was: 11 nm for IPT853, 12 nm for IPT856, 16 nm for IPT1011, and 8 nm for IPT1013.

The AgNP synthesized by the strain IPT1013, presented the most deformed pattern by low structured carbon support (large peak ≈25°) (Wang et al. 2013; Modibedi et al. 2011) due to smaller crystallite size. For IPT853 and IPT1011 AgNP, it was possible to observe two carbon phases structured at 26° and 46° (JCPDF # 18-311), silver oxides (AgO; JCPDF # 76-1489) at 32° and 55°, and Ag2O2 (JCPDF # 51-945) at 57°. These oxides presented a crystallite size around 4 nm.

Size and distribution analysis

The sizes, distribution and polydispersity index (PDI) for AgNP (Table 1) were determined for the strains capable of biosynthesis.

The results obtained through TEM were similar to the ones obtained by DLS. Similar to what was described by Singhal et al. (2011), the size of the metal nanoparticles determined by DLS was slightly larger when compared to the particle size measured from TEM micrographs. According to the authors, this happens because DLS measures the hydrodynamic radius.

Nitrate reductase activity

Nitrate reductase activity of the culture supernatants for the strains IPT853, IPT856, IPT1011, and IPT1013 was detected by the nitrate reductase assay, and analysed over a period of 5 days (Fig. 5). No activity was detected for the remaining strains tested in this study.
Fig. 5

Nitrate reductase activity detected on the fungal cell-free filtrate from the strains capable of AgNP synthesis

Nitrate reductase activity of the isolates capable of nanoparticle synthesis supports the hypothesis of enzymatic reduction of silver nitrate into silver nanoparticles (Hamedi et al. 2013; Saifuddin et al. 2009).

Antibacterial activity of AgNP

Antibacterial activity of biosynthesized AgNP was evaluated by growth inhibition in agar plates. The AgNP showed inhibition of growth of E. coli (Fig. 6a), S. aureus (Fig. 6b) and P. aeruginosa (Fig. 6c).
Fig. 6

Growth inhibition of: a E. coli, b S. aureus, and c P. aeruginosa by different concentrations AgNP of the four synthesizing strains and by streptomycin (used as positive control)

Furthermore, and as expected, no inhibition was detected when using the negative control—water (data not shown).

Discussion

Bioprospection on different and less commonly studied environments allows us to analyse the microbial diversity and encounter microbes specialised in certain bioproducts, like metal nanoparticles. When compared with physical–chemical methods, the microbial biosynthesis of nanoparticles by microorganisms is faster, cheaper, more effective, and without the involvement of hazardous chemicals (Durán et al. 2016; Rahimi et al. 2016). In this study, an initial batch of 20 fungal strain, isolated from sugar cane plantation soil, was screened for its biogenic capacity of producing AgNP by reducing silver nitrate, and four fungal strains (Rhizopus arrhizus IPT1011, Rhizopus arrhizus IPT1013, Trichoderma gamsii IPT853, and Aspergillus niger IPT856) were detected to be capable of biosynthesizing AgNP. According to our measurements, the four selected strains were capable of extracellular biosynthesis of AgNP of uniform size and round-shaped, with diameters in the range of 30–100 nm. Extracellular secretion of enzymes by fungi allows to easily recover those enzymes, which in our study were then used for nanoparticles synthesis, turning this into an effortless biological method.

The exact mechanism of AgNP synthesis by fungi is not yet clearly known but previous studies have indicated that NADH and NADH-dependent nitrate reductases are important factors in the biosynthesis of metal nanoparticles (Ahmad et al. 2003; Hamedi et al. 2013). In the present study, the activity of nitrate reductase was measure for all 20 strains, capable and non-capable of biosynthesizing AgNP. The lack of activity in the cell filtrates for the strains that did not show reduction of silver nitrate supports the hypothesis of enzyme based biosynthesis.

Furthermore, the differences in intensity, shown in Fig. 4, are linked to the structuring process of the silver crystal. The more regular and larger the crystallite formed, the greater the intensity and the smaller the width of the Brag peaks. This structure of the crystals is dependent on the chemical environment, pressure, temperature and time; as these last three factors were constant for all the samples, we can then say that the chemical environment of the fungi was responsible for the differentiation of the structures obtained, which is linked to the Nitrate reductase activity profiles. This activity (Fig. 5), is very low in the initial moments for the strain IPT853 (Trichoderma gamsii), while for IPT1011 (Rhizopus arrhizus) it is more pronounced. We know that the initial moments of nucleation of the nanoparticles dictate the structure and stability of the crystal, and these differences are what caused the appearance of the oxides in other samples. However, all profiles detected by XRD reflect Ag, AgO, AgO2 and carbon particles, with no other contaminant species crystallized.

The AgNP produced by the Rhizopus arrhizus, Trichoderma gamsii and Aspergillus niger strains in this study were found to be active against E. coli, S. aureus, and P. aeruginosa. Multiple bactericidal mechanisms can act in synergy to confer a broad spectrum of activity against different types of bacteria. It is known that the antimicrobial activity of AgNP is due to the formation of insoluble compounds by inactivation of sulfhydryl groups in the cell wall and disruption of membrane bound enzymes and lipids resulting in cell lysis (Dorau et al. 2004). And it has also been reported that the process may involve the binding of AgNP to external proteins to create pores, interfering with DNA replication or forming reactive oxygen species (ROS) such as hydrogen peroxide, superoxide anions, and hydroxyl radicals (Duncan 2011; Durán et al. 2016; Jung et al. 2008).

The AgNP of smaller dimensions in this study, produced by R. arrhizus, were shown to be the most efficient against the bacteria tested. In fact, several studies have shown that AgNP activity is strongly dependent on the NP size (Wu et al. 2014; Tamayo et al. 2014; Rahimi et al. 2016).

The correlation between the bactericidal effect and AgNP concentrations is bacterial class dependent (Chernousova and Epple 2013). Just like in previous studies (Zhang et al. 2014), E. coli was more affected by AgNP than P. aeruginosa and the inhibitory effect on the growth of S. aureus was less marked than in E. coli as previously found by Wu et al. (2014). This strengthens several previous investigations (Pal et al. 2007; Fayaz et al. 2010; Devi and Joshi 2014), that found that Gram-positive and -negative bacteria have different susceptibility to AgNP, probably due to differences in their membranes and cell walls (Feng et al. 2000).

The fact that bacterial resistance to elemental silver is extremely rare (Silver 2003) emphasizes the increased interest in using AgNP as potent antimicrobial agent in biomedical applications. The increase in publications on this topic, like our own research, will benefit future research and development of cost-effective metal nanoparticles production, with desirable therapeutic effects.

The presence of nitrate reductase in the supernatant supports the hypothesis of its strong influence on the mycogenic synthesis process. All the four biosynthesised AgNP were characterised and showed potential antimicrobial activity noted through growth inhibition of several bacterial species. Furthermore, we observed a direct relation between the concentration of AgNP and antimicrobial capacity.

Further analyses are needed to fully understand the mycogenic synthesis process and the mechanisms involved in AgNP production by these strains. Nevertheless, our study proves the importance of exploring more environments and analyse their microbial community to discover novel and/or better bio-products. This will have high impact on society and health, as the world is facing a massive increase of microbial resistance to most of the known and commercially available drugs and antibiotics.

Abbreviations

IPT: 

Instituto de Pesquisa Tecnológica do Estado de São Paulo

AgNP: 

silver nanoparticles

SPR: 

surface plasmon resonance

TEM: 

transmission electron microscopy

EDX: 

energy-dispersive X-ray analysis

XRD: 

X-ray diffraction analysis

Declarations

Authors’ contributions

CAO, MFS, SF, and AEM conceived and designed the experiments; CAO, JGS, RFBS performed the experiments; CA, MFS, SF, ESS, RFBS, AEM analysed the data; CAO, MFS, SF, JGS, RFBS and AEM wrote the paper. All authors read and approved the final manuscript.

Acknowledgements

This work was funded by: Instituto de Pesquisa Tecnológica do Estado de São Paulo/Programa Novos Talentos, through individual research grant attributed to Cristiane Angélica Ottoni. The authors would also like to extend their gratitude to Dr. Almir Oliveira Neto, from Instituto de Pesquisas Energéticas e Nucleares, for his help in completing this research; as well as to the Laboratório de Microscopia do Centro de Ciências e Tecnologia de Materiais (CCTM) for the TEM measurements.

Competing interests

All authors declare that they have no competing interests.

Funding

Instituto de Pesquisa Tecnológica do Estado de São Paulo/Programa Novos Talentos, through individual research grant attributed to Cristiane Angélica Ottoni.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Biosciences Institute, São Paulo State University-UNESP
(2)
Biology Department, Edge Hill University
(3)
Richmond Pharmacology Ltd, St George’s University London
(4)
Laboratório de Biotecnologia Industrial, Instituto de Pesquisa Tecnológica do Estado de São Paulo
(5)
Departamento de Química, Universidade Federal do Amazonas

References

  1. Abdel-Rahim AM, Baghadani AM, Abdalla MH (1983) Studies on the fungus flora in the rhizosphere of sugar cane plants. Mycopathologia 81(3):183–186. doi:10.1007/BF00436825 View ArticleGoogle Scholar
  2. Ahmad A, Mukherjee P, Senapati S, Mandal D, Islam Khan M, Kumar R, Sastry M (2003) Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Coll Surf B 28:313–318. doi:10.1016/S0927-7765(02)00174-1 View ArticleGoogle Scholar
  3. Annamalai J, Nallamuthu T (2016) Green synthesis of silver nanoparticles: characterization and determination of antibacterial potency. Appl Nanosci 6(2):259–265. doi:10.1007/s13204-015-0426-6 View ArticlePubMedGoogle Scholar
  4. Banu A, Rathod V, Ranganath E (2011) Silver nanoparticle production by Rhizopus stolonifer and its antibacterial activity against extended spectrum β-lactamase producing (ESBL) strains of Enterobacteriaceae. Mat Res Bull 46(9):1417–1423. doi:10.1016/j.materresbull.2011.05.008 View ArticleGoogle Scholar
  5. Becaro AA, Jonsson CM, Puti FC, Siqueira MC, Mattoso LHC, Correa DS, Ferreira MD (2015) Toxicity of PVA-stabilized silver nanoparticles to algae and microcrustaceans. Environ Nanotechnol Monit Manag 3:22–29. doi:10.1016/j.enmm.2014.11.002 View ArticleGoogle Scholar
  6. Chan YS, Don MM (2012) Characterization of Ag nanoparticles produced by white-rot fungi and its in vitro antimicrobial activities. Int Arab J Antimicrob Agents 2:1–8. doi:10.3823/717 Google Scholar
  7. Chan YS, Don MM (2013) Biosynthesis and structural characterization of Ag nanoparticles from white rot fungi. Mat Sci Eng C 33:282–288. doi:10.1016/j.msec.2012.08.041 View ArticleGoogle Scholar
  8. Chen D, Li X, Soule T, Yorio F, Orr L (2016) Effects of solution chemistry on antimicrobial activities of silver nanoparticles against Gordonia sp. Sci Total Environ 566:360–367. doi:10.1016/j.scitotenv.2016.05.037 View ArticlePubMedGoogle Scholar
  9. Chernousova S, Epple M (2013) Silver as antibacterial agent: ion, nanoparticle, and metal. Angew Chem Int Ed Engl 52:1636–1653. doi:10.1002/anie.201205923 View ArticlePubMedGoogle Scholar
  10. Cullity BD (1967) In: elements of X-ray diffraction. Addison-Wesley, Massachusetts, p 262Google Scholar
  11. Devi LS, Joshi SR (2014) Evaluation of the antimicrobial potency of silver nanoparticles biosynthesized by using an endophytic fungus, Cryptosporiopsis ericae PS4. J Microbiol 52(8):667–674. doi:10.1007/s12275-014-4113-1 View ArticlePubMedGoogle Scholar
  12. Dorau B, Arango R, Green III F (2004) An investigation into the potential of ionic silver as a wood preservative. In: Proceedings of the 2nd wood-frame housing durability and disaster issues conference Oct 4, pp 133–145Google Scholar
  13. Duncan TV (2011) Applications of nanotechnology in food packaging and food safety: barrier materials, antimicrobials and sensors. J Coll Interface Sci. 363:1–24. doi:10.1016/j.jcis.2011.07.017 View ArticleGoogle Scholar
  14. Durán N, Nakazato G, Seabra AB (2016) Antimicrobial activity of biogenic silver nanoparticles, and silver chloride nanoparticles: an overview and comments. Appl Microbiol Biotechnol. doi:10.1007/s00253-016-7657-7 Google Scholar
  15. Duschak VG (2015) Synthetic biology: computational modeling bridging the gap between in vitro and in vivo reactions. Curr Synthetic Sys Biol 3:127. doi:10.4172/2332-0737.1000127 Google Scholar
  16. Fayaz AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R (2010) Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against Gram-positive and Gram-negative bacteria. Nanomed Nanotechnol Biol Med 6(1):103–109. doi:10.1016/j.nano.2009.04.006 View ArticleGoogle Scholar
  17. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO (2000) A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 52:662–668. doi:10.1002/1097-4636(20001215)52:4<662:AID-JBM10>3.0.CO;2-3 View ArticlePubMedGoogle Scholar
  18. Gopinath V, Velusamy P (2013) Extracellular biosynthesis of silver nanoparticles using Bacillus sp. GP-23 and evaluation of their antifungal activity towards Fusarium oxysporum. Spectrochimica Acta Part A 106:170–174. doi:10.1016/j.saa.2012.12.087 View ArticleGoogle Scholar
  19. Hamedi S, Shojaosadati SA, Shokrollahzadeh S, Hashemi-Najafabadi S (2013) Extracellular biosynthesis of silver nanoparticles using a novel and non-pathogenic fungus, Neurospora intermedia: controlled synthesis and antibacterial activity. World J Microbiol Biotechnol 30:693–704. doi:10.1007/s11274-013-1417-y View ArticlePubMedGoogle Scholar
  20. Jiravova J, Tomankova KB, Harvanova M, Malina L, Malohlava J, Luhova L, Panacek A, Manisova B, Kolarova H (2016) The effect of silver nanoparticles and silver ions on mammalian and plant cells in vitro. Food Chem Toxicol 96:50–61. doi:10.1016/j.fct.2016.07.015 View ArticlePubMedGoogle Scholar
  21. Jung WK, Koo HC, Kim KW, Shin S, Kim SH, Park YH (2008) Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol 74(7):2171–2178. doi:10.1128/AEM.02001-07 View ArticlePubMedPubMed CentralGoogle Scholar
  22. Li Y, Leung P, Yao L, Song QW, Newton E (2006) Antimicrobial effect of surgical masks coated with nanoparticles. J Hosp Infect 62:58–63. doi:10.1016/j.jhin.2005.04.015 View ArticlePubMedGoogle Scholar
  23. Mandal D, Bolander ME, Mukhopadhyay D, Sarkar G, Mukherjee P (2006) The use of microorganisms for the formation of metal nanoparticles and their application. Appl Microbiol Biotechnol 69:485–492. doi:10.1007/s00253-005-0179-3 View ArticlePubMedGoogle Scholar
  24. Mittal AK, Chisti Y, Banerjee UC (2013) Synthesis of metallic nanoparticles using plant extracts. Biotechnol Adv 31(2):346–356. doi:10.1016/j.biotechadv.2013.01.003 View ArticlePubMedGoogle Scholar
  25. Modibedi RM, Masombuka T, Mathe MK (2011) Carbon supported Pd–Sn and Pd–Ru–Sn nanocatalysts for ethanol electro-oxidation in alkaline medium. Int J Hydrog Energy 36(8):4664–4672. doi:10.1016/j.ijhydene.2011.01.028 View ArticleGoogle Scholar
  26. Monteiro DR, Gorup LF, Takamiya AS, Ruvollo-Filho AC, de Camargo ER, Barbosa DB (2009) The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Int J Antimicrob Agents 34(2):103–110. doi:10.1016/j.ijantimicag.2009.01.017 View ArticlePubMedGoogle Scholar
  27. Muthukrishnan S, Bhakya S, Kumar TS, Rao MV (2015) Biosynthesis, characterization and antibacterial effect of plant-mediated silver nanoparticles using Ceropegia thwaitesii—an endemic species. Ind Crops Prod 63:119–124. doi:10.1016/j.indcrop.2014.10.022 View ArticleGoogle Scholar
  28. Ortega FG, Fernández-Baldo MA, Fernández JG, Serrano MJ, Sanz MI, Diaz-Mochón JJ, Lorente JA, Raba J (2015) Study of antitumor activity in breast cell lines using silver nanoparticles produced by yeast. Int J Nanomed 10:2021–2031. doi:10.2147/IJN.S75835 Google Scholar
  29. Pal S, Tak YK, Song JM (2007) Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. App Environ Microbiol 73(6):1712–1720. doi:10.1128/AEM.02218-06 View ArticleGoogle Scholar
  30. Pantidos N, Horsfall LE (2014) Biological synthesis of metallic nanoparticles by bacteria, fungi and plants. J Nanomed Nanotechnol 5:233. doi:10.4172/2157-7439.1000233 View ArticleGoogle Scholar
  31. Paschoalino MP, Marcone GP, Jardim WF (2010) Os nanomateriais e a questão ambiental. Quim Nova 33:421–430. doi:10.1590/S0100-40422010000200033 View ArticleGoogle Scholar
  32. Patel V, Berthold D, Puranik P, Gantar M (2015) Screening of cyanobacteria and microalgae for their ability to synthesize silver nanoparticles with antibacterial activity. Biotechnol Rep 5:112–119. doi:10.1016/j.btre.2014.12.001 View ArticleGoogle Scholar
  33. Rahimi G, Alizadeh F, Khodavandi A (2016) Mycosynthesis of silver nanoparticles from Candida albicans and its antibacterial activity against Escherichia coli and Staphylococcus aureus. Trop J Pharm Res 15(2):371–375. doi:10.4314/tjpr.v15i2.21 View ArticleGoogle Scholar
  34. Roy N, Gaur A, Jain A, Bhattacharya S, Rani V (2013) Green synthesis of silver nanoparticles: an approach to overcome toxicity. Environ Toxicol Pharmacol 36(3):807–812. doi:10.1016/j.etap.2013.07.005 View ArticlePubMedGoogle Scholar
  35. Saifuddin N, Wong CW, Yasumira AA (2009) Rapid biosynthesis of silver nanoparticles using culture supernatant of bacteria with microwave irradiation. J Chem 6(1):61–70. doi:10.1155/2009/734264 Google Scholar
  36. Shanthi S, Jayaseelan BD, Velusamy P, Vijayakumar S, Chih CT, Vaseeharan B (2016) Biosynthesis of silver nanoparticles using a probiotic Bacillus licheniformis Dahb1 and their antibiofilm activity and toxicity effects in Ceriodaphnia cornuta. Microbial Pathog 93:70–77. doi:10.1016/j.micpath.2016.01.014 View ArticleGoogle Scholar
  37. Silver S (2003) Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 27(2–3):341–353. doi:10.1016/S0168-6445(03)00047-0 View ArticlePubMedGoogle Scholar
  38. Singhal G, Bhavesh R, Kasariya K, Sharma AR, Singh RP (2011) Biosynthesis of silver nanoparticles using Ocimum sanctum (Tulsi) leaf extract and screening its antimicrobial activity. J Nanopart Res 13:2981–2988. doi:10.1007/s11051-010-0193-y View ArticleGoogle Scholar
  39. Tamayo LA, Zapata PA, Vejar ND, Azócar MI, Gulppi MA, Zhou X, Thompson GE, Rabagliati FM, Páez MA (2014) Release of silver and copper nanoparticles from polyethylene nanocomposites and their penetration into Listeria monocytogenes. Mater Sci Eng, C 40:24–31. doi:10.1016/j.msec.2014.03.037 View ArticleGoogle Scholar
  40. Thakkar KN, Mhatre SS, Parikh RY (2010) Biological synthesis of metallic nanoparticles. Nanomed Nanotechnol Biol Med 6(2):257–262. doi:10.1016/j.nano.2009.07.002 View ArticleGoogle Scholar
  41. van den Hondel CA, Punt PJ, van Gorcom RF (1992) Production of extracellular proteins by the filamentous fungus Aspergillus. Antonie Van Leeuwenhoek 61(2):153–160. doi:10.1007/BF00580623 View ArticlePubMedGoogle Scholar
  42. Wang H, Liu Z, Ji S, Wang K, Zhou T, Wang R (2013) Ethanol oxidation activity and structure of carbon-supported Pt-modified PdSn-SnO 2 influenced by different stabilizers. Electrochim Acta 108:833–840. doi:10.1016/j.electacta.2013.07.061 View ArticleGoogle Scholar
  43. Wu D, Fan W, Kishen A, Gutmann JL, Fan B (2014) Evaluation of the antibacterial efficacy of silver nanoparticles against Enterococcus faecalis biofilm. J Endod 40(2):285–290. doi:10.1016/j.joen.2013.08.022 View ArticlePubMedGoogle Scholar
  44. Xue B, He D, Gao S, Wang D, Yokoyama K, Wang L (2016) Biosynthesis of silver nanoparticles by the fungus Arthroderma fulvum and its antifungal activity against genera of Candida, Aspergillus and Fusarium. Int J Nanomed 11:1899–1906. doi:10.2147/IJN.S98339 Google Scholar
  45. Zhang M, Zhang K, De Gusseme B, Verstraete W, Field R (2014) The antibacterial and anti-biofouling performance of biogenic silver nanoparticles by Lactobacillus fermentum. Biofouling 30(3):347–357. doi:10.1080/08927014.2013.873419 View ArticlePubMedGoogle Scholar
  46. Zomorodian K, Pourshahid S, Sadatsharifi A, Mehryar P, Pakshir K, Rahimi MJ, Arabi Monfared A (2016) Biosynthesis and characterization of silver nanoparticles by Aspergillus Species. Bio Med Res Int. doi:10.1155/2016/5435397 Google Scholar

Copyright

© The Author(s) 2017